Condition: Idiopathic Hypersomnia · Sponsor: Zevra Therapeutics
This is a study of the safety, efficacy and pharmacokinetics (PK) of Serdexmethylphenidate (SDX) compared to placebo in subjects with Idiopathic Hypersomnia (IH).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Sleep Disorders Center Of Alabama | Birmingham, Alabama, United States | — |
| Amr Daphne | Daphne, Alabama, United States | — |
| Lakeview Clinical Research | Guntersville, Alabama, United States | — |
| SOCAL Clinical Research | Huntington Beach, California, United States | — |
| Stanford University | Redwood City, California, United States | — |
| Sleep Medicine Specialists of California | San Ramon, California, United States | — |
| SDS Clinical Trials, Inc | Santa Ana, California, United States | — |
| Delta Waves, Inc. | Colorado Springs, Colorado, United States | — |
| Saint Francis Sleep Allergy and Lung Institute LLC | Clearwater, Florida, United States | — |
| New Generation of Medical Trials | Hialeah, Florida, United States | — |
| Angels Clinical Research | Miami, Florida, United States | — |
| Ivetmar Medical Group | Miami, Florida, United States | — |
+ 29 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.